Deutsch English Français

Contact

EP3966232

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...

News flashes

Italy joins the Federated Register

Click here for more information on the Federated Register.

2025-06-12

More...

Extract from the Register of European Patents

EP About this file: EP3966232

EP3966232 - INTERFERON REGULATORY FACTOR 5 INHIBITORS AND USES THEREOF [Right-click to bookmark this link]
Status	Request for examination was made Status updated on 11.02.2022 Database last updated on 26.03.2026
Former	The international publication has been made Status updated on 14.11.2020
Most recent event Tooltip	14.03.2026	New entry: Renewal fee paid
Applicant(s)	For all designated states The Feinstein Institutes for Medical Research 350 Community Drive Manhasset, NY 11030 / US
	[2022/11]
Inventor(s)	01 / BARNES, Betsy J. 68 Grove Street Glenwood Landing NY 11547 / US
	02 / SUN, Shan 29 Lake Ellis Road Wingdale NY 12594 / US
	[2022/11]
Representative(s)	De Clercq & Partners Edgard Gevaertdreef 10a 9830 Sint-Martens-Latem / BE
	[2022/11]
Application number, filing date	20802411.7	04.05.2020
	[2022/11]
	WO2020US31283
Priority number, date	US201962844894P	08.05.2019 Original published format: US 201962844894 P
	[2022/11]
Filing language	EN
Procedural language	EN
Publication	Type:	A1 Application with search report
	No.:	WO2020227194
	Date:	12.11.2020
	Language:	EN
	[2020/46]
	Type:	A1 Application with search report
	No.:	EP3966232
	Date:	16.03.2022
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 12.11.2020 takes the place of the publication of the European patent application.
	[2022/11]
Search report(s)	International search report - published on:	US	12.11.2020
	(Supplementary) European search report - dispatched on:	EP	10.05.2023
Classification	IPC:	C07K14/47, C07K19/00, A61P37/02, A61K38/00	[2023/23]
	CPC:	C07K14/4702 (EP); C07K14/47 (US); A61P37/00 (US); A61P37/02 (EP); A61K38/00 (EP,US); C07K2319/10 (EP)
	Former IPC [2022/11]	C07K14/47, C07K19/00
Designated contracting states	AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2022/11]
Title	German:	INTERFERON-REGULIERENDE FAKTOR-5-INHIBITOREN UND DEREN VERWENDUNGEN	[2022/11]
	English:	INTERFERON REGULATORY FACTOR 5 INHIBITORS AND USES THEREOF	[2022/11]
	French:	INHIBITEURS DU FACTEUR 5 DE RÉGULATION DE L'INTERFÉRON ET LEURS UTILISATIONS	[2022/11]
Entry into regional phase	17.11.2021	National basic fee paid
	17.11.2021	Search fee paid
	17.11.2021	Designation fee(s) paid
	17.11.2021	Examination fee paid
Examination procedure	17.11.2021	Examination requested [2022/11]
	20.07.2023	Amendment by applicant (claims and/or description)
Fees paid	Renewal fee
	25.05.2022	Renewal fee patent year 03
	26.05.2023	Renewal fee patent year 04
	13.03.2024	Renewal fee patent year 05
	13.03.2025	Renewal fee patent year 06
	13.03.2026	Renewal fee patent year 07
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:	Search	[A] WO2017044855 (UNIV RUTGERS et al.) [A] 1-15 * abstract; SEQ.3&4 *
		[XA] WO2013151672 (MODERNA THERAPEUTICS et al.) [X] 1-3 * abstract; SEQ. 6653 *[A] 4-15
		[XA] WO2018204764 (CAMP4 THERAPEUTICS CORP et al.) [X] 1-3 * abstract; SEQ. 13814 *[A] 4-15
		[XA] US2016152678 (BANCEL STEPHANE et al.) [X] 1-3 * abstract; SEQ. 6656 *[A] 4-15
	International search	[XY] US2014030218 (UDALOVA IRINA ALEXANDROVNA et al.) [X] 1, 2, 4-7, 16, 19-22, 30, 31 * entire document *[Y] 3, 8, 9, 17, 18, 23, 24, 32
		[Y] US2016009772 (DEMARTINO JULIE et al.) [Y] 3, 8, 9 * entire document *
		[Y] US2018258148 (BAMES BETSY J et al.) [Y] 17, 18, 23, 24, 32 * entire document *
		[A] WO2013151672 (MODERNA THERAPEUTICS et al.) [A] 1-24, 30-32 * entire document *
		[A] US2014273091 (ACTON THOMAS B et al.) [A] 1 -24, 30-32 * entire document *
		[A] THOMPSON CHERRIE D., MATTA BHARATI, BARNES BETSY J.: "Therapeutic Targeting of IRFs: Pathway-Dependence or Structure-Based?", FRONTIERS IN IMMUNOLOGY, vol. 9, no. 2622, 20 November 2018 (2018-11-20), pages 1 - 13, XP055760088, DOI: 10.3389/fimmu.2018.02622 [A] 1-24, 30-32 * . entire document * DOI: http://dx.doi.org/10.3389/fimmu.2018.02622

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.